Member Info for rivaldo

Good to see Ian Martin buying more shares last week whilst I was on hols. He's now bought another £37,000 or so of shares this month at around the current price. Let's hope the mid-April results contain an outlook which confirms his optimism.

Nearly back to the all-time highs, but still only on a current year P/E of 10.8.

Here's the awesome new Aston Martin hypercar just unveiled in public for the first time - CAR's Wipac are named as supplier of all the LED headlights and taillights: Http://www.topspeed.com/cars/car-news/aston-martin-am-rb-001-makes-global-debut-in-toronto-sort-of-ar175962.html The car is designed by Adrian Newey, the legendary Formula One engineer - if he wanted Wipac's products you can be sure that they're the best.

Great to see the overhang cleared and the excellent rise last week whilst I was on hols. With 11.2p historic EPS forecast for 2016, together with a 3.2p dividend - plus a £9m+ cash pile against a £33m m/cap - there would seem to be excellent upside from here.

More new highs now, and ticking up again today despite two 200k trades at 76.5p. QD22, there are very many profitable small/microcap companies which are highly profitable, yet are on reasonable P/E's or are trading at below or not much above tangible asset value. A few suggestions might include INSE, VLE, DKL, SDI, PEG, RTC, XLM and others (if I may, HDD is years away from any profitability and has for many years been a pit of endless fundraisings and unrealised potential! JMO I'm afraid).

Been on hols, so missed the Aston Martin news - the car looks awesome. And the designer is Adrian Newey, who's a Formula One legend of course and must be highly influential as a reference point for SCE approaching other manufacturers: Http://performancedrive.com.au/aston-martin-rb-001-feature-cosworth-v12-engine-1710/ Here's SCE's own press release FYI: Https://surfacetransforms.com/news-blog/2017/2/16/surface-transforms-announced-as-technical-partner-on-aston-martin-am-rb-001

Back from hols, so pleasing to see the share price has performed extremely well given the disappointing contract delay and additional costs. SIM are a microcap who've won extremely large (for their size) government contracts. We all know what can go wrong with such contracts. so delays and spec changes are hardly a surprise, but to a company of SIM's size the effects are highly material. The saving grace from a shareholder POV is of course the cash pile of more than $8m, plus other assets, which nicely supports the current £10m m/cap. Even with this setback SIM will still be profitable for last year with "at least" $0.3m PBT. Finncap have retained their 45p target price. For this year Finncap now forecast 3c EPS, i.e 2.4p EPS, based on $1.6m PBT. Given the contract revenues now deferred into 2017 this looks highly achievable. There will also be 0.7c dividends each year. It's also good to see the intended share buyback programme. The timing of this will be interesting.

Good news this morning: Http://www.investegate.co.uk/gan-plc--gan-/rns/gan-to-distribute-online-games-for-everi-games-inc/201702200700092438X/ Plus Davy are positive about last week's update - EBVITDA breakeven this year would be a big positive: Https://www.davy.ie/research/public/article.htm?id=Davy_Morning_Equity_Briefing_15022017_moneBLinkS0008C0001Cmp.htm "GAN Releases quarterly KPIs for the first time Feb 15 2017, 08:26 GMT Morning briefing 1 page(s) Read Important Disclosures Sectors: Gaming COMPANIES: GAN DAVY VIEW GAN released February 14th some quarterly KPIs which it intends to publish going forward. The data combine simulated and real money activities and, as such, are of limited use from a modelling perspective. However, they do provide an indication of the trajectory of the business. To that end, the near 20% increase in active player days in Q4 over Q3 is encouraging. We would anticipate further good improvements in H1 2017 with four simulated gaming deals due to go live during the period. Our overall view remains unchanged: we believe GAN can be at EBITDA break-even in 2017, based on its pipeline and the relocation of certain operations to a lower-cost European region" Finally, I notice re online gambling in the USA that New York has just passed its first online poker bill of 2017 unanimously and looking promising for this year. With Pennsylvania also looking positive for this year the portents are improving: Http://www.flushdraw.net/news/new-york-online-poker-bill-clears-first-committee-vote/

Stockdale Securities also had this to say last week whilst I was on hols: "Blancco Technology Group 296p; Mkt cap: £172m Blancco Technology is a software company focused on mobile device diagnostics and secure data erasure solutions. The company hosted a Capital Markets Day on 9 February, which was well attended by both the buy and sell side. Positive highlights included: (i) Blancco’s data erasure solutions, which accounted for 97% of FY 16 revenue (30 June YE), which we believe will continue to see strong demand driven by increased regulation and an increased awareness amongst corporates about end of life data permanent data erasure. (ii) The high barriers of entry both with regards to the core IP of Blancco’s data erasure solutions, which have been developed over the course of over a decade, combined with 18 governmental agency standards that Blancco’s has managed to get certified for, including the United States Department of Defense, which is the platinum standard of data erasure. (iii) The foray into indirect sales, which was launched in July 2016 to complement its existing sales channel, could be a game-changer for Blancco in the next 3-5 years. Tie-ups with large IT services’ businesses liked HP Enterprise and Wipro, along with Blancco coming pre-installed on devices by OEM’s like HP, Dell, EMC and Western Digital, could possibly dwarf revenue from the direct sales channel. Blancco’s IP rich data erasure software, with high barriers to entry, a large addressable market which will continue to grow due to regulation and increased number of devices, have led its share price to increase by almost 25% since the start of the year."

Great to see XLM holding presentations for private/retail investors this year post-results on 8th March as well as for institutions. More companies should follow this model - the more that can be learnt about one's investments the better. With $14.4m already spent on two acquisitions this year there will hopefully be upgrades to forecasts for this and next year following the results. As a reminder, current forecasts from Cenkos are: last year : 9.21p EPS, 4.81p divi this year : 9.78p EPS, 5.29p divi Extremely cheap imo given a 103p share price and a $30m or so cash pile. Anyone got Berenberg's forecasts? Their 150p target price is higher than Cenkos' 130p, so I wonder if their estimates are higher accordingly?

Http://money.aol.co.uk/2017/02/19/one-big-yielder-id-buy-and-one-id-sell-in-march/ "One big yielder I'd buy, and one I'd sell, in March By The Motley Fool Feb 19, 2017 Updated: Feb 19th 2017 08:16 AM Shares in Communisis(LSE: CMS) have received a hefty dose of rocket fuel of late, the stock touching 27-month peaks around 50p per share just last week after gaining 38% in value over the past 10 weeks alone. Communisis a month ago announced "trading for the year ended in line with expectations." The company was boosted by a new three-year contract inked with Sony Europe for providing a wide range of communications services. Other notable contract wins include a mammoth deal with HMRC in December, and the City expects the firm's growing international presence and digital delivery expertise to support a stream of fresh contract wins from 2017 onwards. With costs also coming down across the business, Communisis is expected to follow a 13% earnings rise in 2016 with a 6% advance in the current period. And this is predicted to translate into increasingly-tantalising dividends. For 2017 a payout of 2.5p per share is predicted, up from an estimated 2.4p for last year. And this period's projection produces a chunky 5.2% dividend yield, trashing a 3.5% average for Britain's big caps. This year's anticipated payment is also well protected by expected earnings, with coverage of 2.5 times sailing ahead of the safety watermark of 2 times. Furthermore, steadily-improving cash flows should also underpin sterling dividend growth, in my opinion."

Interesting to see the spread close to 2p and the price up despite two 50k sells this morning (they look like sells anyway). The obvious assumption has to be that there's buyers out there in the background. The below link/news may provide a perfect opening for ProReveal across the pond. As regulars will know, Ultraclean Systems is SDI's distribution partner and has already placed the device in hospitals over there. So, with that company now as announced yesterday being exclusively aligned to the giant Getinge Group, there must surely be more than an outside chance that ProReveal could now benefit as the perfect device to assist the instrument cleansing process. Https://www.ultracleansystems.com/category/media-and-press/press-releases/ Another link underlining the case as tech around the instrument space expands: Https://spinalnewsinternational.com/complete-decontamination-of-robotic-instruments-virtually-impossible/ Also, product development news from SDI's Synbiosis: http://www.bioportfolio.com/news/article/3026592/NEW-Chromogenic-ID-software-from-Synbiosis-Makes-identifying-microorganisms-on-HardyCHROM-media.html "Wednesday 15th February 2017 NEW Chromogenic ID software from Synbiosis makes identifying microorganisms on HardyCHROM™ media quick and simple Cambridge, UK: Synbiosis, a long-established, expert manufacturer of automated microbiological systems, today announced its Chromogenic ID software for use with ChromaZona, ProtoCOL 3 and Protos 3 automated colony counters has been upgraded and validated for automatic identification of bacteria and yeast on Hardy Diagnostics' HardyCHROM™ media. Using this new software allows all microbiologists to rapidly generate accurate, objective microbial identification results. The new Chromogenic ID software module, developed in partnership with Hardy Diagnostics, ensures that with minimal training, microbiologists using ChromaZona, ProtoCOL 3, and Protos 3 systems can, at the touch of a button, identify microorganisms based on colour and morphology using a wide range of chromogenic media including: HardyCHROM™; CHROMagar™; Brilliance™ and Colorex™. Using intelligent algorithms to analyse life-like colour plate images captured by ChromaZona, ProtoCOL 3 and Protos 3 systems, the software is so advanced that it can distinguish even turquoise from steel blue colonies. This guarantees precise identification of common pathogens, including Listeriamonocytogenes, Salmonella spp., Shigella spp., methicillin resistant Staphylococcus aureus (MRSA), Cronobacter sakazakii, Candida spp. and E. coli. The Chromogenic ID software provides consistent data and reduces user misidentification errors. The instrument generates accurate results which can be stored in a secure SQL database. This means the software is compliant with CFR 21 part 11 and is ideal for integration into a GLP/GMP environment. To find out more about this innovative softw

here over the last 10 days or so whilst I've been away. Ticking up again today on small buys, so hopefully our seller has disappeared. Lots of upside here imo - and if there's a large acquisition from the £100m+ cash pile then the share price could rocket 50%-100% if all goes well.

Great to see VLE at new highs. VLE were tipped last week in a Motley Fool Micro Cap report. Hopefully the terrific volumes last week following the tip have cleared out Messrs M&Z completely. Has anyone got the full text of the Motley Fool Micro Cap Report - enough time should have passed by now for it to be OK? It would also be interesting to know what other comapnies were tipped.

From Citywire: "Keywords bull run entices Hargreave Citywire AA-rated small cap selector Giles Hargreave has upped his stake in computer game translator Keywords Studios (KWS) as its shares dip from year-long bull-run which took it to a record high. Hargreave increased his holding to just over 5% of the business worth £16.2 million at a share price of 599p, just off an all-time peak of 613p hit last week. The majority of the shares are held by his private clients, with the remainder owned in funds run by his broker and asset manager Hargreave Hale for Marlborough Fund Managers. Keywords offers translation, voice-overs and cultural guidance to computer game developers selling their games into overseas markets, providing services to 21 of the top 25 sector businesses. Keywords is up 159% over the last 12 months. Analyst Berenberg initiated coverage on the company at the start of this money with a ‘buy’ rating and a 760p price target. The shares shed 5.5p on Friday to close the week at 599.5p."

CAR have just been tipped as "stunning value": Http://www.fool.co.uk/investing/2017/02/17/2-secret-growth-stocks-for-savvy-investors/ "A steady stream of contract successes from the automotive sector looks set to keep earnings at Carclo (LSE: CAR) surging in the years ahead, in my opinion — here’s why! Carclo advised last month that at its LED Technologies arm, its Wipac supercar lighting products keep on making a huge impact with the world’s car manufacturers, with the business noting that the segment “continues to win new lighting programmes within the low volume sector”. And Carclo added that it “remains focused on securing a further mid volume programme in the new financial year, which will support the anticipated strong growth of this business”. But the huge potential riches afforded by the fast-growing premium and supercar segments are not the only reasons to get excited about. Carclo’s Technical Products division is also gaining momentum, helped by shrewd bolt-on buys like Precision Tool & Die in October. And the West Yorkshire business is looking to ride this wave by turbocharging its manufacturing capacity in China and India. The City expects Carclo to keep its record of double-digit earnings rises trucking long into the future, and predict a 13% rise in the year to March 2017 to be followed by increases of 13% and 21% in fiscal 2018 and 2019 correspondingly. And these projections make the engineer stunning value for money, in my mind. For the current period Carclo deals on a P/E ratio of just 12 times, and the multiple topples to a mere 10.6 times for next year and 8.8 times for 2019. Furthermore, sub-1 PEG multiples through to the close of 2019 illustrate Carclo’s stunning value relative to its growth prospects."

Great to see INSE attain new highs whilst I was on holiday following the Mail on Sunday tip. And also all the new posters here - I was almost the only person here beforehand! Plenty of upside still left in INSE imho given a current year P/E of only 10.7 based on 1.375p consensus EPS. I particularly liked this extract from the article: "Around 90 per cent of Inspired’s large customers stick with the business and contracts tend to run for several years, so a significant percentage of the company’s future revenues are already known."

Looks like 23k of buys late on Friday afternoon, with presumably no stock around. A couple of small sells today have been easily absorbed, so I'd guess there's still demand for more shares out there.

Good to see CPO prices remaining high at $795. Meanwhile, here's a nice summary of DKL from Northland Securities' February markets summary just out: Http://www.hubinvest.com/AIMPDFFebruary2017_89.pdf "DekelOil plants seed for dividend growth Oil-palm plantations Dividend Oil-palm plantations operator DekelOil is paying a maiden dividend following its move into profit in 2016. A distribution of £500,000 is promised, which is equivalent to 0.17p a share. That should be covered around five times by earnings per share. There is a scrip alternative and some of the directors are going to take part of the payment in shares so the final cash outflow may be lower. The plan is to have a progressive dividend policy. Earnings per share are expected to more than double in 2017 but dividend growth is more likely to be around 10%. DekelOil is able to pay a dividend because the outstanding capital notes were converted into 12.6 million shares at 13.25p each – a 10% premium to the then market price in January. These capital notes were issued in 2010, prior to the company’s flotation in 2013. Business When DekelOil joined AIM less than four years ago it raised money at 1p a share (10p a share after a subsequent ten-for-one share consolidation). DekelOil owned 51% of the Ayenouan palm-oil project near the coast of Côte d’Ivoire and its partner Siva Group had invested €8.3m in the project. The joint venture company held rights over additional land in the Guitry region of Côte d’Ivoire. The plan was to build a crude-palmoil extraction mill with an intended capacity of 70,000 tonnes a year and construction was completed at the end of 2013. In 2014, the national government granted 100% exemption from corporation tax for profit generated from the mill up until the end of 2026. A kernel-crushing plant was subsequently added. Over the past year, DekelOil has taken its stake in the joint venture to 100%. In 2016, revenues increased by 12% to €26.1m. Crude-palm-oil sales improved from 35,573 tonnes to 39,498 tonnes but the average price fell by 5% to €575/tonne. However, prices have been rising and they reached €700/tonne at the end of 2016....DekelOil broke even in 2015 and it is expected to make a 2016 pre-tax profit of €2.6m, although this is much lower than originally expected because of poor weather later in the year. The dividend announcement suggests that management is confident that the plantation’s performance will continue to improve. The 2017 pre-tax profit forecast has been reduced from €7.9m to €6.5m. The shares are trading on seven times prospective, non-taxed 2017 earnings, although the multiple does depend on the euro/pound exchange rate. DekelOil has made impressive progress over a four-year period and there is more growth to come."

Interesting article including this section on how BLTG is an early stage growth company: Https://*********************/blogs/the-naked-fund-manager/anatomy-of-a-growth-company "Blancco is, by some margin, the market leader in data erasure services. It is 7x the size of its nearest competitor according to Equity Development and has been around and growing nicely for some years. However, there are long-awaited regulatory changes now just around the corner that should be a boon for the sector. The new EU data protection law is coming into effect in May 2018. Aside from the regulatory tailwind, the data erasure market is a growing and Blancco has grown revenues 50% pa over the last two years. To get comfortable with whether or not the shares offer an attractive opportunity, you need to build an impression of how big the market could get, and over what timescale. You will need to gauge competitive threats and barriers to entry to ascertain how wide Blancco’s moat is. Finally, this should allow you to build a picture of Blancco’s future earnings and therefore value. Based on the latest Trading Update and broker forecasts, 2016 revenues look like they will come in around £23m, 50% up on 2015. Brokers brave enough to forecast to 2020 are estimating growth to take revenues to over £50m which considering current organic growth and regulatory tailwinds doesn’t seem too far-fetched. Applying a 25% margin to this, and a reasonable multiple can easily get you to an attractive premium over the current market cap. These assumptions may well prove hopelessly wrong, to the good or bad, so that’s why you then need to build in a safety buffer. Whatever your view of the company, it, and the industry it leads, faces a fascinating 24 months."